149 related articles for article (PubMed ID: 10022378)
1. Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients.
Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
J Immunol Methods; 1999 Jan; 222(1-2):111-24. PubMed ID: 10022378
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
[TBL] [Abstract][Full Text] [Related]
3. Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.
Lambert JS; Viscidi R; Walker MC; Clayman B; Winget M; Wolff M; Schwartz DH
Clin Diagn Lab Immunol; 1997 May; 4(3):302-8. PubMed ID: 9144368
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers.
Rubinstein A; Goldstein H; Pettoello-Mantovani M; Mizrachi Y; Bloom BR; Furer E; Althaus B; Que JU; Hasler T; Cryz SJ
AIDS; 1995 Mar; 9(3):243-51. PubMed ID: 7755912
[TBL] [Abstract][Full Text] [Related]
5. IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects.
Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
AIDS Res Hum Retroviruses; 2000 Apr; 16(6):583-94. PubMed ID: 10777149
[TBL] [Abstract][Full Text] [Related]
6. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.
Funkhouser A; Clements ML; Slome S; Clayman B; Viscidi R
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):627-32. PubMed ID: 8369168
[TBL] [Abstract][Full Text] [Related]
8. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
Mestecky J; Jackson S; Moldoveanu Z; Nesbit LR; Kulhavy R; Prince SJ; Sabbaj S; Mulligan MJ; Goepfert PA
AIDS Res Hum Retroviruses; 2004 Sep; 20(9):972-88. PubMed ID: 15585085
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
[TBL] [Abstract][Full Text] [Related]
10. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk.
Nelson CS; Pollara J; Kunz EL; Jeffries TL; Duffy R; Beck C; Stamper L; Wang M; Shen X; Pickup DJ; Staats HF; Hudgens MG; Kepler TB; Montefiori DC; Moody MA; Tomaras GD; Liao HX; Haynes BF; Ferrari G; Fouda GGA; Permar SR
J Virol; 2016 May; 90(10):4951-4965. PubMed ID: 26937027
[TBL] [Abstract][Full Text] [Related]
11. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
[TBL] [Abstract][Full Text] [Related]
13. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
Belshe RB; Graham BS; Keefer MC; Gorse GJ; Wright P; Dolin R; Matthews T; Weinhold K; Bolognesi DP; Sposto R
JAMA; 1994 Aug; 272(6):475-80. PubMed ID: 7913731
[TBL] [Abstract][Full Text] [Related]
15. Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
Akapirat S; Karnasuta C; Vasan S; Rerks-Ngarm S; Pitisuttithum P; Madnote S; Savadsuk H; Rittiroongrad S; Puangkaew J; Phogat S; Tartaglia J; Sinangil F; de Souza MS; Excler JL; Kim JH; Robb ML; Michael NL; Ngauy V; O'Connell RJ; Karasavvas N;
PLoS One; 2018; 13(4):e0196397. PubMed ID: 29702672
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.
Gorse GJ; Rogers JH; Perry JE; Newman FK; Frey SE; Patel GB; Belshe RB
Vaccine; 1995 Feb; 13(2):209-14. PubMed ID: 7625118
[TBL] [Abstract][Full Text] [Related]
17. HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
McGuire EP; Fong Y; Toote C; Cunningham CK; McFarland EJ; Borkowsky W; Barnett S; Itell HL; Kumar A; Gray G; McElrath MJ; Tomaras GD; Permar SR; Fouda GG
J Virol; 2018 Jan; 92(1):. PubMed ID: 29021402
[TBL] [Abstract][Full Text] [Related]
18. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
Staats HF; Nichols WG; Palker TJ
J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
[TBL] [Abstract][Full Text] [Related]
20. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
